News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AmpliPhi Biosciences (TGEN) Shareholder Update


2/1/2012 6:26:51 AM

RICHMOND, Va. & SEATTLE, Wash. & COLWORTH, England--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (APHB.PK), the leader in the development of bacteriophage-based anti-bacterial therapies to treat drug resistant infections, today provides the following update to shareholders on progress made during 2011.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES